Today, most advanced people constantly talk about crypto-technology. What is its general meaning ICO? These are instant payments from one point of the world to another, low commissions or their complete absence, security of personal data and decentralization. But in general, this is of course the fact that crypto-technologies improve the quality of our life. Particularly valuable are the blockchain technology in the field of medicine. Here, more than ever, new ideas, decentralization and the desire to make this world better are important. It is in this area that Shivom operates.
Shivom is a global ecosystem of gene medicine and public health. Within this ecosystem, a gene database will be formed, where donors will be able to mix their gene data, and medical and pharmacological companies conduct research and development.
What problem prompted the team to create the Shivom project? The matter is that now there is no free access to DNA data, there is no safe storage and there are no qualitative developments. Borders between countries and differences in legislative bases do not allow donors to place their DNA data.
All this is suggested by Shivom. In this ecosystem, each donor can place data on his gene, and only he manages them, the degree of openness, etc. Naturally, the donor will do this for a reward from potential buyers (various companies from the field of health). All the data is stored in an encoded form thanks to the blockchain.
Now imagine what a huge amount of DNA data will be available for research and development. There will be a qualitative leap in the treatment of cancer (it is known that for lung cancer there are vulnerable two genes - EGFR and ALK), HIV, cardiovascular and many others.
To implement all forethought things Shivom is based on blockchain technologies, where three key nodes can be distinguished: Decentralized applications (DApp), Ethereum Blockchain (for token operation), Hyperledger Fabric (for smart contracts).
A distributed registry technology is being developed, based on Hyperledger Fabric, the BigchainDB (Decentralized Data Exchange, Ocean protocol) platform and IOTA Tangle (for streaming and collecting medical data through medical / IoT devices).
To control the perfect actions within the platform, a mobile application is designed. Users will always be able to control their data, information about payments, etc. The data owner will be able to find out to which companies his genomic data was transferred, and how much he earned from it. All payments on the platform will be made using ERC-20 token based on Ethereum, OmiX.
Users of the Shivom platform are:
clients (donors providing their data);
medical institutions;
pharmacological companies;
state structures (for the search for health strategies, prevention of mass epidemics);
scientists and researchers;
third-party developers of programs related to health, medicine, a healthy lifestyle.
The Whitepaper of the project is presented on the Shivom website - https://shivom.io/files/Whitepaper.pdf
Whitepaper is compiled very competently and accessible. There is a description of the problem, Shivom solutions, detailed steps, roadmap, project sciencetronic and acquaintance with team members. From what I liked in Whitepaper I can say that Shivom plans to introduce such interesting things through the mobile application as daily monitoring of one's own health, consultations on nutrition, fitness, predisposition to diseases, etc.
Also, close cooperation with medical institutions is planned. So, pharmacies will be able to offer their clients a gene test Shivom, after which he immediately will have diagnosis. In general, a lot of cool marketing partnerships are planned in the project.
I want to note the latest news that the statement of the government of the Indian state Andhra Pradesh with a population of more than 60 million people about close partnership and cooperation with Shivom on diagnostics of DNA of the inhabitants of the state. (https://techobserver.in/article/egov/andhra-pradesh-signs-mou-with-genomics-firm-shivom-to-use-blockchain-for-predictive-medicine-privacy-of-citizens-dna-data )
Negotiations are also ongoing with the government of Basel, Switzerland and Dubai, the UAE. In the near future it is planned to sign an agreement with the governments of these countries. The project cooperates with the Ocean protocol and the Spherity protocol as technical partners; Hitbtc, Bancor and Btcalpha as partners in liquidity, Jaxx and Coinomi as partners in wallet, etc.
ICO and tokenometric of the project
Within the ICO, a OmiX token will be released, which is a key part of the Shivom platform
OmiX is designed for operations inside the platform, receiving remuneration, etc.
After the completion of the ICO, the token will be traded on the crypto-exchanges.
As I already wrote above the ERC-20 token.
Total volume of OmiX tokens: 3 billion
Token: OMX
Price: 1 ETH = 7000 OMX
Platform: Ethereum
Currency: ETH, BTC, Fiat
Soft cap: 15,000 ETH
Hard cap: 75,000 ETH
TOKEN SALE: April 16 - May 16
Tokens will be distributed as follows:
33% will be sold on ICO (990 million tokens)
14% - to founders (420 million tokens)
10% - to early partners and advisors (300 million tokens)
20% - project development fund (600 million tokens)
20% - reserve fund (600 million tokens)
3% - reserved for the community in the form of a bounty (90 million)
Distribution of income:
25% - installation of laboratories
21% - marketing and partnerships
20% - development of the platform
11% - operations and project development
10% - R & D, non-commercial drug discovery platform
5.5% - data storage
5% - legal procedures
2.5% - sequencing
The project has already got $ 40 million from funds: Collinstar Capital, Lateral Capital Ventures, Ironside Capital, Discovery Capital, Springview Capital, DigitalX, etc. These funds do not belong to the ICO, these funds have already been collected for the implementation of the project.
Command
Team experience: All team members have great experience in their field.
The team consists of 6 co-founders, 11 managers and 7 members of the Innovation Council.
One of the co-founders is CEO - PhD in human genetics with more than 15 years of experience and 3 successful companies in the field of genomics.
The Chief Technical Adviser is among TOP-100 influential people in the field of the blockchain.
CMO is among the top 10 most influential people in the blockchain technology, an adviser to Forbes and the British government.
CIO is a venture capital partner in DraperDragon, formerly a partner of DFJ Dragon Fund and DragonVenture, and was the founder of Global Chamber® San Francisco and a member of the Advisory Board in several IT companies in Silicon Valley.
CSO is a co-founder of the IOTA Foundation, worked in Carlsberg, IKEA, WPP and other international companies.
For the marketing promotion of Shivom, a generous (bounty) campaign is carried out, all conditions are available at the link - https://bitcointalk.org/index.php?topic=3183600
More detailed information about the project you can learn by studying Whitepaper -https://shivom.io/documents.html
as well as on information resources:
►WEBSITE: https://shivom.io/
►FACEBOOK: https://www.facebook.com/ProjectShivom
►TWITTER: https://twitter.com/projectshivom
►TELEGRAM: https://t.me/projshivom
►ANN: https://bitcointalk.org/index.php?topic=2365709.msg24124494#msg24124494
►REDDIT: https://www.reddit.com/r/Shivom/
►MEDIUM: https://medium.com/@projectshivom
►My link Bitcointalk: https://bitcointalk.org/index.php?action=profile;u=1245936
►My username Bitcointalk: uliss_and